Revance Therapeutics | RVNC - Modal Dan Cadangan



Modal Dan Cadangan Perubahan Tanggal
AbbVie USD -3.27B 628M 2025-12
ALKERMES USD 1.82B 85.86M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Cara Therapeutics USD 32.93M 41M 2025-06
Coherus Biosciences USD 61.01M 26.76M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
J&J USD 78.47B 0 2025-09
Merck USD 51.85B 2.79B 2025-09
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
P&G USD 53.32B 234M 2025-12
Pacira USD 693.11M 34.1M 2025-12
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12